Thomas G. Turi
Corporate Officer/Principal bei COVANCE INC.
Profil
Thomas G.
Turi is currently the Vice President-Biomarkers at Labcorp Drug Development, Inc. He started this position in 2013.
Prior to his current role, he has worked at Labcorp Drug Development, Inc. since 2008.
In terms of education, Dr. Turi completed his undergraduate degree at the University of Illinois.
He then went on to earn a doctorate degree from The University of Cincinnati College of Medicine.
Aktive Positionen von Thomas G. Turi
Unternehmen | Position | Beginn |
---|---|---|
COVANCE INC. | Corporate Officer/Principal | 01.12.2008 |
Ausbildung von Thomas G. Turi
University of Illinois | Undergraduate Degree |
The University of Cincinnati College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |